Leiters, Compounding Health Vancomycin IV Bags, Phenylephrine IV Bags recall: Potential for superpotent drug
Potential for superpotent drug



The hazard: Potency, impurity or stability failure
The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
What the notice says: Risk Statement: There is a reasonable probability that the use of the defective vancomycin and fentanyl IV bags will be associated with life-threatening adverse events.
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Published
- January 5, 2024
- Risk level
- Elevated risk
- Issued by
- U.S. Food and Drug Administration
- Brand
- Leiters, Compounding Health
- Product type
- Prescription & OTC drugs
- Distribution
- Nationwide
Products covered by this recall
Vancomycin IV Bags, Phenylephrine IV Bags, and Fentanyl IV Bags
What the company announced
FOR IMMEDIATE RELEASE – January 5, 2024 – Englewood, Colorado, Leiters Health is voluntarily recalling 33 lots of products listed below to the user level. The recalled batches of vancomycin IV bags, phenylephrine IV bags, and fentanyl IV bags are being recalled due to the potential for superpotency because they may contain twice the labeled amount of drug. The semi-automated IV bag filling equipment used to fill the recalled batches may not eject the IV bags properly when compressed air tanks become low or a leak was detected, causing the recalled IV bags to be dosed twice.
- Item #: F3355 · Product Description: FentaNYL 1000 mcg (10 mcg/mL) (as FentaNYL Citrate) PF (from API) added to 0.9% Sodium Chloride 100 mL IV bag · Lot #: 2331062 · Expiration: 2/8/2024
- Item #: 2331224 · Product Description: 3/18/2024
- Item #: 2331270 · Product Description: 3/28/2024
- Item #: F3342 · Product Description: FentaNYL 2500 mcg (10 mcg/mL) (as FentaNYL Citrate) PF (from API) added to 0.9% Sodium Chloride 250 mL IV bag · Lot #: 2330988 · Expiration: 1/31/2024
- Item #: 2331058 · Product Description: 2/18/2024
- Item #: 2331150 · Product Description: 3/10/2024
- Item #: 2331231 · Product Description: 3/24/2024
- Item #: 2331289 · Product Description: 3/30/2024
- Item #: F3360 · Product Description: Phenylephrine HCl 20 mg (80 mcg/mL) (from FDP) added to 0.9% Sodium Chloride 250 mL IV Bag · Lot #: 2330993 · Expiration: 2/15/2024
- Item #: 2331010 · Product Description: 2/10/2024
- Item #: 2331055 · Product Description: 1/18/2024
- Item #: 2331113 · Product Description: 2/26/2024
- Item #: 2331181 · Product Description: 3/4/2024
- Item #: 2331187 · Product Description: 3/23/2024
- Item #: 2331266 · Product Description: 3/31/2024
- Item #: 2331343 · Product Description: 4/1/2024
- Item #: 2331349 · Product Description: 4/23/2024
- Item #: 2331433 · Product Description: 5/5/2024
- Item #: F3352 · Product Description: Phenylephrine HCl 40 mg (160 mcg/mL) (from FDP) added to 0.9% Sodium Chloride 250 mL IV Bag · Lot #: 2330939 · Expiration: 1/30/2024
- Item #: 2331032 · Product Description: 2/3/2024
- Item #: 2331112 · Product Description: 3/19/2024
- Item #: 2331190 · Product Description: 3/26/2024
- Item #: 2331429 · Product Description: 4/28/2024
- Item #: F3206 · Product Description: Vancomycin HCl 1.25 g PF added to 0.9% Sodium Chloride 250 mL IV Bag · Lot #: 2331184 · Expiration: 2/13/2024
- Item #: 2331185 · Product Description: 2/10/2024
- Item #: 2331189 · Product Description: 2/20/2024
- Item #: 2331191 · Product Description: 2/24/2024
- Item #: 2331258 · Product Description: 3/3/2024
- Item #: 2331317 · Product Description: 3/15/2024
- Item #: F3208 · Product Description: Vancomycin HCl 1.5 g PF added to 0.9% Sodium Chloride 250 mL IV Bag · Lot #: 2331140 · Expiration: 2/8/2024
- Item #: 2331188 · Product Description: 2/15/2024
- Item #: 2331261 · Product Description: 3/5/2024
- Item #: 2331287 · Product Description: 3/14/2024
Risk Statement: There is a reasonable probability that the use of the defective vancomycin and fentanyl IV bags will be associated with life-threatening adverse events. Administration of vancomycin at twice the infusion rate has been associated with low blood pressure, including shock and cardiac arrest, as well as wheezing, shortness of breath, hives, itchy skin and skin redness. Also, overdosing of vancomycin may be associated with acute kidney injury and ototoxicity. Administration of higher doses of fentanyl than intended can result in profound respiratory depression, which may not automatically be mitigated and treated, resulting in potential for delay in care and serious adverse outcomes from hypoxia, including permanent neurologic sequelae and death. In addition to respiratory depression, fentanyl can cause serious cardiac adverse events, such as hypotension, bradycardia, and vasodilation resulting in decrease in cardiac output and cardiac arrest. In addition, administration of a higher dose of phenylephrine than intended may cause higher-than-intended blood pressures in some patients.
To date, Leiters Health has not received any reports of adverse events related to this recall.
Fentanyl is an analgesic packaged in an IV bag under codes F3355 and F3342. Phenylephrine is used for perioperative hypotension, hypotension during anesthesia, and shock and is packaged in an IV bag under codes F3360 and F3352.
Vancomycin is used for endocarditis and staphylococcal infections and is packaged in an IV bag under codes F3206 and F3208.
The products were distributed nationwide to hospitals for administration in the hospital. Leiters Health has notified its customers by a letter sent via mail, requiring signature upon receipt, and an email to all affected customers. Leiters Health is arranging for a credit for all recalled products. Customers that have product which is being recalled should cease using it and return it to Leiters Health.
Consumers with questions regarding this recall can contact Leiters Health by phone at 1-800-292-6772 or e-mail at [email protected] Monday through Friday between 8:00 AM MST and 5:30 PM MST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products. Customers will receive return shipping labels for phenylephrine and vancomycin returns via email from Leiters Health to return their products to Leiters Health at 13796 Compark Blvd., Englewood, CO 80112. Customers will receive return shipping labels, along with a DEA Form 222, for fentanyl returns via mail from Leiters Health to return their products to Leiters Health at 13796 Compark Blvd., Englewood, CO 80112.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Reproduced from the company announcement posted on fda.gov. Links and contact forms in the original are not repeated here; the official notice below has them.
Check your product
The notice names 35 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 2331062
- 2330988
- 2330993
- 2330939
- 2331184
- 2331140
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 2/8/2024
- 1/31/2024
- 2/15/2024
- 1/30/2024
- 2/13/2024
Model or item number
On the rating label, the box or the instruction sheet.
- F3355
- 2331224
- 2331270
- F3342
- 2331058
- 2331150
- 2331231
- 2331289
- F3360
- 2331010
- 2331055
- 2331113
- 2331181
- 2331187
- 2331266
- 2331343
- 2331349
- 2331433
- F3352
- 2331032
Package size
Match the net weight or the piece count on the front of the pack.
- 100 mL
- 250 mL
- 20 mg
- 40 mg
Codes are lifted verbatim from the FDA — Company recall announcements notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Potency
Leiters, Compounding Health — The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Do not stop a prescription on your own. For most conditions an uncertain dose is safer than no dose while you get advice.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
- Keep the carton and the leaflet — the lot number is usually printed only on the outer pack.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Remedy named in the notice: Customers that have product which is being recalled should cease using it and return it to Leiters Health.
Company contact: Leiters Health — Consumers: Leiters Health, 1-800-292-6772, [email protected] — Media: Kari Cashmore, Vice President Marketing, (720) 414-7216
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Company recall announcements record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Leiters, Compounding Health prescription & otc drugs recalled?
Potential for superpotent drug Risk Statement: There is a reasonable probability that the use of the defective vancomycin and fentanyl IV bags will be associated with life-threatening adverse events.
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 2331062, 2330988, 2330993; best-by date 2/8/2024 or 1/31/2024; model number F3355, 2331224, 2331270. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
The notice says: Customers that have product which is being recalled should cease using it and return it to Leiters Health.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 12 days ago
Houston Rx LLC Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution recall: Lack of process control
Lack of process control
-
Class II · 12 days ago
Teva Pharmaceuticals USA, Inc Metoclopramide Tablets, USP, 5 mg recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class II · 12 days ago
American Health Packaging Metoclopramide Tablets, USP, 5 mg, 100 Tablets recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class II · 12 days ago
Zydus Pharmaceuticals Inc Hydrocortisone Sodium Succinate for Injection recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications.
-
Class II · 12 days ago
Houston Rx LLC Tirzepatide/Niacinamide 2mL vial Inj 20mg/2mg/mL recall: Lack of assurance of sterility
Lack of assurance of sterility.
-
Class II · 19 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility